Literature DB >> 6419453

IGA mesangial glomerulonephritis; significance and pathogenesis of segmental-focal glomerular lesions.

G Syré.   

Abstract

A review of 430 renal biopsies from patients with various nephropathies processed by light microscopy, immunofluorescence and in part by electron microscopy revealed 82 cases with diffuse mesangial IgA deposition. Sixty-three cases appearing without signs of systemic disease were included in this study. The glomerular changes consisted of mesangial increase (31 cases mild, and 32 cases severe) and segmental-focal glomerular lesions (40 cases). Immunofluorescence revealed granular deposits of immunoglobulins and complement within the mesangium (IgG 9, IgM 25, IgA 63, C3 27, C1q 0) as well as segmentally in the wall of capillary loops (IgG 4/26, IgM 20/26, IgA 0/26, C3 16/26, C1q 7/26). Electron microscopic studies (40 cases) showed electron dense deposits in the mesangial region in all biopsies and deposits either electron dense (11 cases) or radiolucent (26 cases) at various sites along the basement membrane of capillary loops. Comparison between morphological findings and clinical data showed a significant correlation between segmental-focal glomerular lesion on the one hand, and proteinuria (p less than 0.01), immune deposits along the capillary basement membrane (p less than 0.01), and the increased mesangium (p less than 0.001) on the other. Considering the macromolecular mesangial clearing function, the segmental-focal glomerular lesions may be due to newly arrived, infection related immune complexes which may not be cleared promptly by the mesangium, because its clearing function is impaired due to IgA deposition.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6419453     DOI: 10.1007/BF00695045

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  23 in total

1.  Immunoglobulin A nephropathy.

Authors:  S W Zimmerman; P M Burkholder
Journal:  Arch Intern Med       Date:  1975-09

2.  The clinical course of IgA nephropathy in adults.

Authors:  J van der Peet; L Arisz; J R Brentjens; J Marrink; P J Hoedemaeker
Journal:  Clin Nephrol       Date:  1977-08       Impact factor: 0.975

Review 3.  IgA-Associated glomerulonepbritis.

Authors:  D C Lowance; J D Mullins; J J McPhaul
Journal:  Int Rev Exp Pathol       Date:  1977

4.  IgA nephropathy.

Authors:  R C McCoy; C R Abramowsky; C C Tisher
Journal:  Am J Pathol       Date:  1974-07       Impact factor: 4.307

5.  IgA glomerular deposits in renal disease.

Authors:  J Berger
Journal:  Transplant Proc       Date:  1969-12       Impact factor: 1.066

6.  Immunohistochemical demonstration of hepatitis B core and surface antigens in paraffin sections.

Authors:  S N Huang
Journal:  Lab Invest       Date:  1975-07       Impact factor: 5.662

7.  Is there a treatment of mesangial IgA glomerulonephritis?

Authors:  G Lagrue; T Sadreux; J Laurent; G Hirbec
Journal:  Clin Nephrol       Date:  1981-09       Impact factor: 0.975

8.  Glomerulonephritis with mesangial deposits of IgA unassociated with systemic disease.

Authors:  A Katz; B J Underdown; J O Minta; I H Lepow
Journal:  Can Med Assoc J       Date:  1976-02-07       Impact factor: 8.262

9.  Mesangial proliferative glomerulonephritis.

Authors:  H K Bhasin; J G Abuelo; R Nayak; A R Esparza
Journal:  Lab Invest       Date:  1978-07       Impact factor: 5.662

10.  IgA-IgG nephropathy: predictive indices of progressive disease.

Authors:  S A Hood; J A Velosa; K E Holley; J V Donadio
Journal:  Clin Nephrol       Date:  1981-08       Impact factor: 0.975

View more
  2 in total

1.  Mesangial cell autoantigens in immunoglobulin A nephropathy and Henoch-Schönlein purpura.

Authors:  D J O'Donoghue; A Darvill; F W Ballardie
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

2.  An acute model for IgA-mediated glomerular inflammation in rats induced by monoclonal polymeric rat IgA antibodies.

Authors:  R K Stad; J A Bruijn; D J van Gijlswijk-Janssen; L A van Es; M R Daha
Journal:  Clin Exp Immunol       Date:  1993-06       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.